Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment.
O. Hovardovska (Kharkiv, Ukraine), O. Schevchenko (Kharkiv, Ukraine), L. Todoriko (Kharkiv, Ukraine), O. Pogorelova (Kharkiv, Ukraine), O. Shvets (Kharkiv, Ukraine), I. Ovcharenko (Kharkiv, Ukraine)
Source: Virtual Congress 2020 – Tuberculosis and society
Session: Tuberculosis and society
Session type: E-poster session
Number: 1456
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Hovardovska (Kharkiv, Ukraine), O. Schevchenko (Kharkiv, Ukraine), L. Todoriko (Kharkiv, Ukraine), O. Pogorelova (Kharkiv, Ukraine), O. Shvets (Kharkiv, Ukraine), I. Ovcharenko (Kharkiv, Ukraine). Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment.. 1456
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Immunologic rates and cytokine blood profile in different age groups patients with pulmonary tuberculosis Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009
Efficacy of different preoperational treatment in patients with destructive pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005
Study of the system of hemostasis in patients with chronic forms of pulmonary sarcoidosis (PS) with impairments of regional pulmonary blood circulation Source: Eur Respir J 2006; 28: Suppl. 50, 537s Year: 2006
Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients Source: Eur Respir J 2003; 22: Suppl. 45, 521s Year: 2003
Kinetics of plasma osteopontin during treatment in patients with pulmonary tuberculosis. A preliminary study Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008
Central/effector memory T-cell dynamics in the peripheral blood of patients with active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 10s Year: 2002
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Treatment results in patients with drug resistant pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
Monitoring of new pulmonary TB patients: detection and treatment Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Genetic markers of blood in patients with acute progressing forms of tuberculosis of the lungs Source: Eur Respir J 2007; 30: Suppl. 51, 202s Year: 2007
A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017
The comparison of subsets of blood lymphocytes in patients with lung cancer,COPD,and tuberculosis according to healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease - including a long-term follow-up study Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Peripheral blood leukocyte subsets as markers of early TB treatment response Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2007; 30: Suppl. 51, 203s Year: 2007
Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
Immunophenotypic characterisation of peripheral blood mononuclear cells in patients with MDR pulmonary tuberculosis Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016